Literature DB >> 35474387

A rationalized definition of general tumor suppressor microRNAs excludes miR-34a.

Sophie Mockly1, Élisabeth Houbron1, Hervé Seitz1.   

Abstract

While several microRNAs (miRNAs) have been proposed to act as tumor suppressors, a consensual definition of tumor suppressing miRNAs is still missing. Similarly to coding genes, we propose that tumor suppressor miRNAs must show evidence of genetic or epigenetic inactivation in cancers, and exhibit an anti-tumorigenic (e.g., anti-proliferative) activity under endogenous expression levels. Here we observe that this definition excludes the most extensively studied tumor suppressor candidate miRNA, miR-34a. In analyzable cancer types, miR-34a does not appear to be down-regulated in primary tumors relatively to normal adjacent tissues. Deletion of miR-34a is occasionally found in human cancers, but it does not seem to be driven by an anti-tumorigenic activity of the miRNA, since it is not observed upon smaller, miR-34a-specific alterations. Its anti-proliferative action was observed upon large, supra-physiological transfection of synthetic miR-34a in cultured cells, and our data indicates that endogenous miR-34a levels do not have such an effect. Our results therefore argue against a general tumor suppressive function for miR-34a, providing an explanation to the lack of efficiency of synthetic miR-34a administration against solid tumors.
© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2022        PMID: 35474387      PMCID: PMC9071449          DOI: 10.1093/nar/gkac277

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   19.160


  27 in total

Review 1.  The Functions of MicroRNAs: mRNA Decay and Translational Repression.

Authors:  Hiro-Oki Iwakawa; Yukihide Tomari
Journal:  Trends Cell Biol       Date:  2015-10-01       Impact factor: 20.808

2.  Inconsistencies and Limitations of Current MicroRNA Target Identification Methods.

Authors:  Sophie Mockly; Hervé Seitz
Journal:  Methods Mol Biol       Date:  2019

3.  Frequent downregulation of miR-34 family in human ovarian cancers.

Authors:  David C Corney; Chang-Il Hwang; Andres Matoso; Markus Vogt; Andrea Flesken-Nikitin; Andrew K Godwin; Aparna A Kamat; Anil K Sood; Lora H Ellenson; Heiko Hermeking; Alexander Yu Nikitin
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

Review 4.  microRNAs as oncogenes and tumor suppressors.

Authors:  Baohong Zhang; Xiaoping Pan; George P Cobb; Todd A Anderson
Journal:  Dev Biol       Date:  2006-08-16       Impact factor: 3.582

5.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

6.  miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

Authors:  Elena Gallardo; Alfons Navarro; Nuria Viñolas; Ramon M Marrades; Tania Diaz; Bernat Gel; Angels Quera; Eva Bandres; Jesus Garcia-Foncillas; Jose Ramirez; Mariano Monzo
Journal:  Carcinogenesis       Date:  2009-09-07       Impact factor: 4.944

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Authors:  Tsung-Cheng Chang; Erik A Wentzel; Oliver A Kent; Kalyani Ramachandran; Michael Mullendore; Kwang Hyuck Lee; Georg Feldmann; Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein; Dan E Arking; Michael A Beer; Anirban Maitra; Joshua T Mendell
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

Review 9.  Recessive mechanisms of malignancy.

Authors:  A R Green
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

10.  miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110.

Authors:  Rui Song; Peter Walentek; Nicole Sponer; Alexander Klimke; Joon Sub Lee; Gary Dixon; Richard Harland; Ying Wan; Polina Lishko; Muriel Lize; Michael Kessel; Lin He
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

View more
  2 in total

1.  Sequestration of LINE-1 in cytosolic aggregates by MOV10 restricts retrotransposition.

Authors:  Rajika Arora; Maxime Bodak; Laura Penouty; Cindy Hackman; Constance Ciaudo
Journal:  EMBO Rep       Date:  2022-07-20       Impact factor: 9.071

2.  Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a.

Authors:  Fangteng Liu; Nassim Bouznad; Markus Kaller; Xiaolong Shi; Janine König; Stephanie Jaeckel; Heiko Hermeking
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.